ELA vs LLY · P/E 21, rev $155.2M vs P/E 39, rev $22.97B
Envela Corp (ELA) versus Eli Lilly and Company (LLY) — a side-by-side from cached financials, not a winner call.
Envela Corp (ELA) is a luxury goods company listed on US.
Eli Lilly and Company (LLY) is a drug manufacturers - general company listed on NYSE. It is led by David Ricks.
Latest reported ELA revenue for 2026-06-30 was $155.2M. Net income was $13.0M. Revenue was up 57.7% from 2026-03-31 to 2026-06-30. ELA currently screens at market cap $158.1M and trailing P/E 21.0.
Latest reported LLY revenue for 2026-06-30 was $22.97B. Net income was $7.09B. Revenue was up 16.0% from 2026-03-31 to 2026-06-30. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
ELA currently screens at market cap $158.1M and trailing P/E 21.0. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
Not investment advice. Open the ELA and LLY stock pages for the full models.
Not investment advice.